Aviv Regev leads Genentech’s next revolution with AI

SOUTH SAN FRANCISCO  At Genentech, many of the company’s drug designers are making molecules for a machine that are, for lack of a better word, weird.

The new molecules don’t look like they’ll be better drugs. They don’t always make sense. But they make the computer happier. And as America’s…
Click here to view original post

Advertisement — Advertise with Biotech Networks